H35.12
Retinopathy of prematurity, stage 1
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinopathy of Prematurity (ROP) is a condition affecting the eyes of premature infants, potentially leading to vision problems or blindness if not properly managed. Stage 1 ROP is the earliest stage of this disease, characterized by subtle changes in the blood vessels in the retina. Recognizing and understanding this stage is essential for early intervention and management to prevent progression and preserve vision.
Causes & Symptoms
Clinical Causes: Premature birth, especially before 31 weeks of gestation Low birth weight, typically under 1500 grams (3 pounds 4 ounces) Extended oxygen therapy or high oxygen levels after birth Genetic factors that affect vascular development in the eye
Key Symptoms: No noticeable symptoms in the early stage Abnormal blood vessel growth in the retina detected during eye examinations Potentially appearing as a faint or flat abnormality upon examining the retina
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Stage 1 ROP typically involves a comprehensive eye examination performed by a pediatric ophthalmologist. The examination includes dilating the infant’s pupils to visualize the retina and assess blood vessel development. The International Classification of Retinopathy of Prematurity (ICROP) provides a standardized staging system, with Stage 1 characterized by a demarcation line separating vascularized and avascular retina. Regular follow-up exams are critical to monitor the disease's progression or regression.
Treatment Protocols: In Stage 1 ROP, observation is often the primary management approach, as the condition frequently resolves on its own without intervention. However, infants require close monitoring to detect any progression to more advanced stages. If ROP advances to stages 3 or 4, treatment options may include laser therapy or cryotherapy to halt abnormal blood vessel growth. In some cases, anti-vascular endothelial growth factor (anti-VEGF) medications can be considered under specialized medical guidance. Early detection and intervention are vital to minimizing long-term vision problems.
Clinical Advice & FAQs
Billing Guidance
Is H35.12 a billable ICD-10 code?
Yes, H35.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.12?
Clinical documentation must specify the nature of Retinopathy of prematurity, stage 1 and any associated comorbidities for accurate reporting.
Cite this Clinical Reference